Literature DB >> 12614232

A spectrum of skin reactions caused by the tyrosine kinase inhibitor imatinib mesylate (STI 571, Glivec).

A Drummond, P Micallef-Eynaud, W S Douglas, I Hay, T L Holyoake, M W Drummond.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614232     DOI: 10.1046/j.1365-2141.2003.04151_4.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  Systemic Steroid Treatment for Imatinib-Associated Severe Skin Rash in Patients with Gastrointestinal Stromal Tumor: A Phase II Study.

Authors:  Eo Jin Kim; Min-Hee Ryu; Sook Ryun Park; Mo Youl Beck; Woo Jin Lee; Mi Woo Lee; Yoon-Koo Kang
Journal:  Oncologist       Date:  2020-07-12

2.  Imatinib-induced Stevens-Johnsons syndrome.

Authors:  Praveen Jha; D Himanshu; Nirdesh Jain; Ajay Kumar Singh
Journal:  BMJ Case Rep       Date:  2013-01-23

3.  Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity.

Authors:  Caterina Musolino; Alessandro Allegra; Carmen Mannucci; Sabina Russo; Andrea Alonci; Valerio Maisano; Gioacchino Calapai; Sebastiano Gangemi
Journal:  Turk J Haematol       Date:  2015-06       Impact factor: 1.831

Review 4.  European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.

Authors:  J L Steegmann; M Baccarani; M Breccia; L F Casado; V García-Gutiérrez; A Hochhaus; D-W Kim; T D Kim; H J Khoury; P Le Coutre; J Mayer; D Milojkovic; K Porkka; D Rea; G Rosti; S Saussele; R Hehlmann; R E Clark
Journal:  Leukemia       Date:  2016-04-28       Impact factor: 11.528

Review 5.  Cutaneous complications of molecular targeted therapy used in oncology.

Authors:  I Lupu; N Voiculescu; N Bacalbasa; I Cojocaru; V Vrancian; C Giurcaneanu
Journal:  J Med Life       Date:  2016 Jan-Mar

Review 6.  IL-31, itch and hematological malignancies.

Authors:  Eleonora Di Salvo; Alessandro Allegra; Marco Casciaro; Sebastiano Gangemi
Journal:  Clin Mol Allergy       Date:  2021-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.